Description

Cilnidipine Film-Coated Tablets (5 mg / 10 mg / 20 mg)

Healthy Inc is a specialized global supplier and exporter of advanced cardiology, nephrology, and targeted 4th-generation antihypertensive therapeutics. We provide ultra-high-purity, kinetically optimized Cilnidipine Film-Coated Tablets (5 mg / 10 mg / 20 mg), manufactured in WHO–GMP certified, strictly light-protected and humidity-controlled oral solid dosage facilities. This “Dual L/N-Type Calcium Channel Blocker” is a massive-volume, high-margin export to cardiology networks, renal care clinics, retail pharmacy chains, and government health ministries in LATAM, the CIS, Africa, and Southeast Asia, serving as the globally mandated, side-effect-free upgrade to older CCBs for the management of Essential Hypertension and Diabetic Nephropathy.

Product Overview

This highly advanced formulation operates as a sophisticated, dual-action vascular and neurological dampener. Unlike older drugs that blindly force blood vessels open (causing fluid to leak into the legs), Cilnidipine coordinates the dilation of the vascular bed while simultaneously silencing the sympathetic nerves that cause the heart to race.

The “Dual L/N-Type CCB & Renal Protector” Specialist:

• Mechanism 1 (The L-Type Arterial Blockade): Like all CCBs, Cilnidipine blocks L-type calcium channels in the smooth muscle of the blood vessels. This prevents calcium from entering the cells, forcing the rigid, hypertensive arteries to physically relax and dilate, causing a smooth, sustained drop in systemic blood pressure.
• Mechanism 2 (The N-Type Sympathetic Sparing Advantage): The defining clinical superiority of Cilnidipine is its ability to also block N-type calcium channels located at the sympathetic nerve endings. When blood pressure drops, the brain normally panics and fires sympathetic nerves to increase the heart rate (reflex tachycardia) and constrict veins. By blocking these N-type channels, Cilnidipine silences this panic signal. It dilates the veins alongside the arteries, preventing the capillary pressure buildup that causes the severe pedal edema (ankle swelling) notoriously associated with Amlodipine.
• Mechanism 3 (Glomerular Decompression): In the kidneys, L-type blockers only dilate the incoming (afferent) blood vessels, which can actually increase pressure inside the delicate filtration units (glomeruli). Because Cilnidipine also blocks N/T-type channels, it dilates the outgoing (efferent) vessels as well. This instantly drops intraglomerular pressure, halting the leakage of protein (proteinuria) and actively protecting the kidneys in diabetic patients.

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Cardiology Distributors, and Hospital Procurement Boards.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Photolytic Defense & Lipophilic Solubilization (CRITICAL COMPLIANCE): Cilnidipine presents two major manufacturing hurdles: it is practically insoluble in water, and it degrades rapidly upon exposure to light. Our cardiology suites utilize advanced high-shear wet granulation with highly calibrated surfactants to guarantee rapid, complete gastric dissolution. We then apply a specialized, ultra-dense opaque film coating. We guarantee global procurement boards a flawless, bioequivalent formulation that will not fail on the pharmacy shelf.

Therapeutic Indications (Human Use)

Indicated for the targeted, highly specialized lifelong management of cardiovascular and renal stress:

• Essential Hypertension: First-line management of high blood pressure, particularly in patients who have experienced intolerable side effects (pedal edema, tachycardia) from older dihydropyridine CCBs like Amlodipine.
• Hypertension with Co-morbidities: Highly preferred for hypertensive patients suffering from concurrent Chronic Kidney Disease (CKD), Diabetic Nephropathy, or baseline tachycardia, due to its unique renal-protective and heart-rate-lowering profile.

Dosage & Administration

Recommended Dosage (Strictly as per Cardiologist Guidelines):

• Standard Adult Dosing: Initially 5 mg to 10 mg taken orally once daily in the morning after breakfast. The dose may be adjusted up to 20 mg once daily based on clinical response.
• Administration: Best taken consistently at the same time each day to maintain a flat, 24-hour pharmacokinetic curve.
• Hepatic Impairment: Cilnidipine is extensively metabolized by the liver. Patients with severe hepatic dysfunction must be initiated on the lowest possible dose (5 mg) and monitored closely for hypotension.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Severe Hypotension: As a potent vasodilator, it can cause sudden, symptomatic hypotension (dizziness, syncope), particularly in volume-depleted patients or those taking concurrent antihypertensives (like diuretics or ARBs).
• Aortic Stenosis Contraindication: Strictly contraindicated in patients with severe aortic stenosis, as the massive peripheral vasodilation can catastrophically reduce blood flow to the coronary arteries.
• Unstable Angina / Acute MI: Should be avoided within the first few weeks following an acute myocardial infarction or in patients with unstable angina, as safety in these acute settings is not fully established.
• Drug Interactions (CYP3A4): Heavily metabolized by CYP3A4. Co-administration with strong CYP3A4 inhibitors (e.g., Ketoconazole, Ritonavir) will violently spike blood levels of Cilnidipine, leading to profound cardiovascular collapse.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving international Pharma Traders, Wholesalers, and Cardiology Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Antihypertensives, 4th Generation CCBs, and Light-Shielded Formulations. Whether you are looking for a reliable Government Tender Supplier for chronic disease programs in Africa or a B2B Pharma Marketplace partner for the CIS, our highly regulated logistics network ensures timely, secure delivery of WHO-GMP certified products.